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Previewsto the ERGIC, from which they trigger un-
abated type I IFN expression. The reason
for this constitutive STING translocation
to the ERGIC remains unclear; however,
as the authors suggest, it is possible that
these mutations disrupt the interaction of
STINGwith anER-resident retentionsignal
that normally prevents the exiting of STING
toward the ERGIC in the absence of stimu-
lation. Interestingly, these STING mutants
were not translocated to the above-
mentioned punctate structures, and they
were also largely resistant to degradation.
While the latter phenomenon could be ex-
plainedby the lack of an additional cGAMP
signal that seems to be required to facili-
tate STING degradation (Konno et al.,
2013), the authors furthermore show that
additional cGAS activation does not
initiate the decay of this type of STINGmu-
tants. Thus, it appears that a special struc-
tural feature of activated, wild-type STINGat the ERGIC is required to allow its exit
from this compartment for subsequent
degradation. In this regard it should be
informative to further dissect the mecha-
nisms that facilitate STING transport
beyond the ERGIC.
Collectively, the data provided by the
new study assign an important role to
the ERGIC in STING signaling, adding
this unique organelle to the ever-growing
list of subcellular compartments that
serve as platforms for the initiation of
anti-microbial signal transduction. Further
dissection of STING trafficking may
inform the design of specific therapeutic
strategies, geared at the inhibition of
STING in the context of sterile inflamma-
tory conditions.REFERENCES
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Dectin-1, a b-glucan receptor, contributes to host anti-fungal defense. In this issue of Cell Host & Microbe,
Tang et al. (2015) show that suppressing Dectin-1 signaling protects mice from experimental colitis by
decreasing anti-microbial peptide production, which allows overgrowth of Lactobacilli and triggers T regu-
latory cell expansion in the gut.Mammalian gastrointestinal (GI) tract is
colonized with diverse commensal
microbial communities consisting of bac-
teria, fungi, and viruses. The host
mucosal immune system has evolved
to tolerate and control this complex
ecosystem while ensuring responses
against invading pathogens. Deficiencies
in genes involved in key innate and adap-
tive immune pathways often lead to
disorders characterized by intestinal
manifestations and loss of microbial di-
versity, or so called dysbiosis. Many of
these pathways play a role in the interac-
tion with bacteria and viruses. Recent
studies have shown that deficiencies ingenes encoding factors involved in anti-
fungal immunity can also contribute to
diseases targeting the mammalian GI
tract (Underhill and Iliev, 2014). The
fungal counterpart (mycobiota) of the
intestinal microbiota has attracted scien-
tific attention as a possible disease
component during these deficiencies.
Among different antifungal receptors,
Dectin-1 has been extensively studied
for its important role in fungal phagocy-
tosis, killing, and cytokine response. Dec-
tin-1 is a transmembrane receptor that
recognizes fungal b-glucan (Taylor et al.,
2007). Mice deficient in Dectin-1 are high-
ly susceptible to invasive fungal diseasedue to decreased ability of phagocytes
to sense, kill, and respond to Candida
(Taylor et al., 2007). This predisposition,
however, is dependent on the fungal
strain suggesting that some fungi are
able to more efficiently mask cell wall
b-glucans and become invisible to Dec-
tin-1. In addition to its role in systemic
protection against fungi, there is sufficient
evidence that Dectin-1 is involved in the
host control of fungi at various body sur-
faces, including the skin (Kashem et al.,
2015), lungs (Werner et al., 2009), vagina
(Carvalho et al., 2012), and the GI tract
(Carvalho et al., 2012; Iliev et al., 2012;
Plantinga et al., 2009) with some, August 12, 2015 ª2015 Elsevier Inc. 139
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Figure 1. Proposed Model for the Role of Dectin-1 in the Gut
In this issue, Tang et al. (2015) demonstrate that in the absence of opportunistic fungi in the gut, Dectin-1
stimulation by luminal glucans presumably coming from commensal fungi, food, or mucins aggravate
experimental colitis in mice. They further show that suppression of Dectin-1 signaling protects mice
from experimental colitis by decreasing S100A8 and S100A9 antimicrobial peptide production. This allows
the overgrowth of L. murinus that trigger T regulatory cell expansion in the gut (left panel). On the other
hand, when opportunistic fungi are present in the intestine, absence of Dectin-1 can allow for fungal inva-
sion of the intestinal mucosa and can be detrimental during colitis (right panel). Thus, on one side, Dectin-1
deficiency can have a positive effect on the expansion of bacteria with protective properties, but on the
other, it can lead to inability of the host to properly deal with opportunistic fungi in the gut.
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Previewsdiscrepancies between specific mouse
strains and humans.
Although during fungal overgrowth and
infection Dectin-1 has a protective role,
there are reports supporting the notion
that in models where fungal commensals
or pathogens are not present, ligation of
Dectin-1 can lead to inflammatory cyto-
kine response and has a detrimental ef-
fect to the host (Rosas et al., 2008; Yosh-
itomi et al., 2005). Therefore, depending
on the context, Dectin-1 can protect the
host against invading fungi but can also
be involved in aggravating inflammation.
In this issue of Cell Host & Microbe,
Tang et al. (2015) focus on this second
aspect and demonstrate that Dectin-1
suppression can ameliorate intestinal
inflammation under specific circum-
stances. They show that in the absence
of opportunistic fungal commensals,
Dectin-1 can indirectly control bacterial
populations in the gut through Dectin-1-
dependent anti-microbial peptide (AMP)
production. Lack of Dectin-1 signaling
can affect AMP production and facilitate
the expansion of the gut commensal140 Cell Host & Microbe 18, August 12, 2015Lactobacilli that are protective during
colitis (Figure 1).
Tang et al. (2015) start with a curious
observation: that in their mouse colony,
mice lacking Dectin-1 (Clec7a/) were
more resistant to chemically induced
colitis when compared to the wild-type
(WT) controls. Transfer of microbiota
from conventional SPF Clec7a/ mice
into a WT germ-free (GF) host conveyed
resistance to chemically induced colitis
while specific pathogen-free (SPF) WT
microbiota transplantation conferred sus-
ceptibility, suggesting Dectin-1-depen-
dent selection for microbiota with ‘‘pro-
tective’’ properties. Dectin-1 deficiency
itself was not directly involved in this
phenotype, as WT GF and Clec7a/ GF
mice transferred with WT SPF microbiota
experienced similar degree of disease
severity.
A recent study demonstrated that
mice lacking Dectin-1 exhibit increased
susceptibility to colitis, as a result of
altered responses to indigenous fungi
and invasion of the colonic mucosa by
opportunistic fungi such as Candida andª2015 Elsevier Inc.Trichosporon (Iliev et al., 2012). However,
Candida tropicalis, which was causing the
colitis susceptibility in Clec7a/ mice in
this former study, was not detected in
the mouse colony of Tang et al. (2015).
Notably, Tang et al. (2015) showed that
upon colonization with C. tropicalis, the
protection from colitis was completely
lost and Clec7a/ mice became highly
susceptible to colitis when compared to
the WT controls. This suggests a dual
role of Dectin-1 in the gut, which is highly
dependent on the microbiota makeup
(Figure 1).
In attempt to explain the observed
Clec7a/ protective phenotype in the
absence of opportunistic commensal
fungi, the authors next analyzed the bac-
terial gut microbiota composition in WT
and Clec7a/ mice. Upon bacterial 16S
deep sequencing analysis, they found a
marked increase of Lactobacillus murinus
in Clec7a/ mice but not in WT controls.
Lactobacillus species have been recog-
nized as an essential part of a balanced
intestinal community and have been
shown to participate in the maintenance
of protective immunity at the gut and
the vaginal mucosa. Therefore, the
authors went to investigate whether the
increase of L. murinus may contribute to
colitis protection in Clec7a/ mice.
They found that GF mice monocolonized
with L. murinus followed by WT SPF
microflora transfer are protected against
colitis when compared to mice colonized
only with WT SPF microflora or mono-
colonized with Alcaligenes faecalis—
another commensal bacteria found in the
mouse colon. This protection was associ-
ated with an increase of IL-10-producing
CD4+ T cells in the colonic lamina propria
of these mice. Interestingly, Clec7a/
Rag2/ mice, which lack T and B cells,
were not protected from DSS colitis,
although L. murinus intestinal population
was still augmented, suggesting that
components of the T or B cell repertoire
are responsible for the observed protec-
tion. Consistently, increase of L. murinus
in Rag2-sufficient Clec7a/ mice was
associated with infiltration of Foxp3+
T regulatory (Treg) cells in their colons
and protection from colitis. To specifically
explore the role of L. murinus in Treg cell
expansion, GF mice were monocolonized
with this strain. Monocolonization with
L. murinus, but not with A. faecalis, led
to increased Treg cell infiltration in the
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tween lactobacilli and Treg cells that
might protect mice against colitis.
When SPF WT microflora was trans-
ferred into GF mice, L. murinus expanded
quickly inClec7a/GF host but not in the
WTGFmice, suggesting Dectin-1-depen-
dent control of lactobacilli. How does
Dectin-1 influence the size of lactobacilli
population in the gut? After excluding
the possibility of a direct recognition of
L. murinus by Dectin-1, the authors
explored an indirect mechanism of lacto-
bacilli population control by this receptor.
One possible scenario is that Dectin-1
stimulation can influence local immunity
and indirectly affect lactobacilli. The
authors explored this possibility further
and found that the absence of Dectin-1
is associated with decreased AMP pro-
duction in the intestines of Clec7a/
mice. They also found that L. murinus
was susceptible to S100A8 and S100A9,
two AMPs that were reduced in the
colons of Clec7a/ mice. Furthermore,
blockage of Dectin-1 signaling in WT
SPF mice by the soluble b-glucan lami-
narin ameliorated colitis and was associ-
ated with reduced AMP production and
increased L. murinus in the intestine of
these mice. This suggested that Dectin-1
blockage might be protective during coli-
tis through inhibition of AMP production
and expansion of potentially beneficial
bacteria in the colon. Finally, Lactoba-
cillus salivarius, a strain that is closely
related to the murine L. murinus, was
reduced in the feces of patients with
Crohn’s disease, demonstrating that
intestinal disease and related dysbiosis
affects the lactobacilli population also in
humans.
Overall, Tang et al. (2015) reveal a role
for Dectin-1 in indirect control of lactoba-
cilli in the gut; however, some questions
remain. What will be the consequence of
Dectin-1 suppression when opportunistic
commensal fungi are present in the gut?
Candida species are commonly found inthe human intestine, and potential thera-
peutic suppression of Dectin-1 might be
a double-edged sword: on one side,
it might have a positive effect on the
expansion of bacteria with protective
properties, but on the other, it can lead
to inability of the host to properly deal
with opportunistic fungi in the gut.
Although C. tropicalis was absent in the
mouse colony used in the present study,
Dectin-1 stimulation by other commensal
fungi in the intestinal lumen cannot be
excluded. Despite some challenges,
the next-generation sequencing tech-
nologies have allowed for deeper explo-
ration of host-associated mycobiota
and have prompted recent efforts in the
development of bioinformatics tools and
databases for ‘‘mycobiome’’ character-
ization and analysis. Therefore, such
improved tools can be used to further
characterize the gut mycobiota in various
Clec7a/ mouse colonies. In addition to
commensal fungi, future studies need to
explore the relative contribution of other
Dectin-1 ligands in the gut, such as intes-
tinal mucin-associated or dietary glucans
that might affect Dectin-1-dependent
AMP production. What is the mechanism
by which Dectin-1 induces AMP pro-
duction and which are the mediators of
this phenomenon? Although Tang et al.
(2015) show that intestinal epithelial cells
(IECs) express low levels of Dectin-1,
others have demonstrated that IECs can
respond to b-glucans. It is also possible
that Dectin-1-expressing immune cells
that are sensing b-glucans in the lamina
propria can affect AMP production
through crosstalk with IECs. Does Dec-
tin-1-dependent AMP production influ-
ence other Gram-positive bacteria, and
can Dectin-1 suppression predispose
the host to infection with specific Gram-
positive pathogens? Finally, are there
other cells besides Tregs that are influ-
enced by lactobacilli and might contribute
to the protective phenotype during Dec-
tin-1 deficiency?Cell Host & Microbe 18Despite some questions that still need
to be addressed in the future, the study
of Tang et al. (2015) provides an important
insight on the role of Dectin-1 in mucosal
immunity and underscores the dual con-
trol that this receptor exerts on fungal
and bacterial communities in the gut.
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